Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
31,654
archived clinical trials in
Cardiology

NIT-OCCLUD PDA Phase II Sentinel Trial
Transcatheter Occlusion of Patent Ductus Arteriosus (PDA) With the NIT-OCCLUD PDA Occlusions System
Status: Enrolling
Updated:  3/21/2018
Riley Hospital for Children
1867
mi
from 98109
Indianapolis, IN
NIT-OCCLUD PDA Phase II Sentinel Trial
Transcatheter Occlusion of Patent Ductus Arteriosus (PDA) With the NIT-OCCLUD PDA Occlusions System
Status: Enrolling
Updated: 3/21/2018
Riley Hospital for Children
1867
mi
from 98109
Indianapolis, IN
Click here to add this to my saved trials
NIT-OCCLUD PDA Phase II Sentinel Trial
Transcatheter Occlusion of Patent Ductus Arteriosus (PDA) With the NIT-OCCLUD PDA Occlusions System
Status: Enrolling
Updated:  3/21/2018
Children's Hospital of Iowa
1558
mi
from 98109
Iowa City, IA
NIT-OCCLUD PDA Phase II Sentinel Trial
Transcatheter Occlusion of Patent Ductus Arteriosus (PDA) With the NIT-OCCLUD PDA Occlusions System
Status: Enrolling
Updated: 3/21/2018
Children's Hospital of Iowa
1558
mi
from 98109
Iowa City, IA
Click here to add this to my saved trials
NIT-OCCLUD PDA Phase II Sentinel Trial
Transcatheter Occlusion of Patent Ductus Arteriosus (PDA) With the NIT-OCCLUD PDA Occlusions System
Status: Enrolling
Updated:  3/21/2018
Children's Hospital of Akron
2041
mi
from 98109
Akron, OH
NIT-OCCLUD PDA Phase II Sentinel Trial
Transcatheter Occlusion of Patent Ductus Arteriosus (PDA) With the NIT-OCCLUD PDA Occlusions System
Status: Enrolling
Updated: 3/21/2018
Children's Hospital of Akron
2041
mi
from 98109
Akron, OH
Click here to add this to my saved trials
NIT-OCCLUD PDA Phase II Sentinel Trial
Transcatheter Occlusion of Patent Ductus Arteriosus (PDA) With the NIT-OCCLUD PDA Occlusions System
Status: Enrolling
Updated:  3/21/2018
Columbus Children's Hospital
2010
mi
from 98109
Columbus, OH
NIT-OCCLUD PDA Phase II Sentinel Trial
Transcatheter Occlusion of Patent Ductus Arteriosus (PDA) With the NIT-OCCLUD PDA Occlusions System
Status: Enrolling
Updated: 3/21/2018
Columbus Children's Hospital
2010
mi
from 98109
Columbus, OH
Click here to add this to my saved trials
NIT-OCCLUD PDA Phase II Sentinel Trial
Transcatheter Occlusion of Patent Ductus Arteriosus (PDA) With the NIT-OCCLUD PDA Occlusions System
Status: Enrolling
Updated:  3/21/2018
St. Christopher's Hospital for Children
2374
mi
from 98109
Philadelphia, PA
NIT-OCCLUD PDA Phase II Sentinel Trial
Transcatheter Occlusion of Patent Ductus Arteriosus (PDA) With the NIT-OCCLUD PDA Occlusions System
Status: Enrolling
Updated: 3/21/2018
St. Christopher's Hospital for Children
2374
mi
from 98109
Philadelphia, PA
Click here to add this to my saved trials
NIT-OCCLUD PDA Phase II Sentinel Trial
Transcatheter Occlusion of Patent Ductus Arteriosus (PDA) With the NIT-OCCLUD PDA Occlusions System
Status: Enrolling
Updated:  3/21/2018
Driscoll Children's Hospital
1919
mi
from 98109
Corpus Christi, TX
NIT-OCCLUD PDA Phase II Sentinel Trial
Transcatheter Occlusion of Patent Ductus Arteriosus (PDA) With the NIT-OCCLUD PDA Occlusions System
Status: Enrolling
Updated: 3/21/2018
Driscoll Children's Hospital
1919
mi
from 98109
Corpus Christi, TX
Click here to add this to my saved trials
NIT-OCCLUD PDA Phase II Sentinel Trial
Transcatheter Occlusion of Patent Ductus Arteriosus (PDA) With the NIT-OCCLUD PDA Occlusions System
Status: Enrolling
Updated:  3/21/2018
Children's Medical Center of Dallas
1676
mi
from 98109
Dallas, TX
NIT-OCCLUD PDA Phase II Sentinel Trial
Transcatheter Occlusion of Patent Ductus Arteriosus (PDA) With the NIT-OCCLUD PDA Occlusions System
Status: Enrolling
Updated: 3/21/2018
Children's Medical Center of Dallas
1676
mi
from 98109
Dallas, TX
Click here to add this to my saved trials
NIT-OCCLUD PDA Phase II Sentinel Trial
Transcatheter Occlusion of Patent Ductus Arteriosus (PDA) With the NIT-OCCLUD PDA Occlusions System
Status: Enrolling
Updated:  3/21/2018
Children's Hospital and Regional Medical Center - Seattle
3
mi
from 98109
Seattle, WA
NIT-OCCLUD PDA Phase II Sentinel Trial
Transcatheter Occlusion of Patent Ductus Arteriosus (PDA) With the NIT-OCCLUD PDA Occlusions System
Status: Enrolling
Updated: 3/21/2018
Children's Hospital and Regional Medical Center - Seattle
3
mi
from 98109
Seattle, WA
Click here to add this to my saved trials
Preventing Hypotension in Parturients With an Elevated Body Mass Index (BMI)
A Double Blind Randomized Controlled Trial of Phenylephrine for the Prevention of Spinal Induced Hypotension in Obese Parturients
Status: Enrolling
Updated:  3/22/2018
Duke Univ Med Ctr
2341
mi
from 98109
Durham, NC
Preventing Hypotension in Parturients With an Elevated Body Mass Index (BMI)
A Double Blind Randomized Controlled Trial of Phenylephrine for the Prevention of Spinal Induced Hypotension in Obese Parturients
Status: Enrolling
Updated: 3/22/2018
Duke Univ Med Ctr
2341
mi
from 98109
Durham, NC
Click here to add this to my saved trials
Preventing Hypotension in Parturients With an Elevated Body Mass Index (BMI)
A Double Blind Randomized Controlled Trial of Phenylephrine for the Prevention of Spinal Induced Hypotension in Obese Parturients
Status: Enrolling
Updated:  3/22/2018
IWK Health Centre
2752
mi
from 98109
Halifax,
Preventing Hypotension in Parturients With an Elevated Body Mass Index (BMI)
A Double Blind Randomized Controlled Trial of Phenylephrine for the Prevention of Spinal Induced Hypotension in Obese Parturients
Status: Enrolling
Updated: 3/22/2018
IWK Health Centre
2752
mi
from 98109
Halifax,
Click here to add this to my saved trials
Evaluating the Risk of Cognitive Impairment After Surgical and Transcatheter Aortic Valve Replacement
Proposal for Collection of Patient Data to Aid in Design of an Observational Study (i.e. Preparatory to Research) Evaluating Risk of Cognitive Impairment After Surgical and Transcatheter Valve Replacement.
Status: Enrolling
Updated:  3/22/2018
Minneapolis VA Health Care System
1391
mi
from 98109
Minneapolis, MN
Evaluating the Risk of Cognitive Impairment After Surgical and Transcatheter Aortic Valve Replacement
Proposal for Collection of Patient Data to Aid in Design of an Observational Study (i.e. Preparatory to Research) Evaluating Risk of Cognitive Impairment After Surgical and Transcatheter Valve Replacement.
Status: Enrolling
Updated: 3/22/2018
Minneapolis VA Health Care System
1391
mi
from 98109
Minneapolis, MN
Click here to add this to my saved trials
Genetic Risk and Health Coaching for Type 2 Diabetes and Coronary Heart Disease
Genetic Risk and Health Coaching for Type 2 Diabetes and Coronary Heart Disease
Status: Enrolling
Updated:  3/24/2018
David Grant Medical Center
646
mi
from 98109
Fairfield, CA
Genetic Risk and Health Coaching for Type 2 Diabetes and Coronary Heart Disease
Genetic Risk and Health Coaching for Type 2 Diabetes and Coronary Heart Disease
Status: Enrolling
Updated: 3/24/2018
David Grant Medical Center
646
mi
from 98109
Fairfield, CA
Click here to add this to my saved trials
EEG Characteristics in Youth POTS and/or Syncope
Electroencephalographic (EEG) Characteristics of Postural Tachycardia Syndrome (POTS) and Syncope (Without POTS) During Head-upright Tilt Table Testing
Status: Enrolling
Updated:  3/25/2018
Nationwide Children's Hopsital
2009
mi
from 98109
Columbus, OH
EEG Characteristics in Youth POTS and/or Syncope
Electroencephalographic (EEG) Characteristics of Postural Tachycardia Syndrome (POTS) and Syncope (Without POTS) During Head-upright Tilt Table Testing
Status: Enrolling
Updated: 3/25/2018
Nationwide Children's Hopsital
2009
mi
from 98109
Columbus, OH
Click here to add this to my saved trials
Study of BioNIR Drug Eluting Stent System in Coronary Stenosis
BioNIR Ridaforolimus Eluting Coronary Stent System (BioNIR) In Coronary Stenosis Trial
Status: Enrolling
Updated:  3/25/2018
Piedmont Healthcare
2177
mi
from 98109
Atlanta, GA
Study of BioNIR Drug Eluting Stent System in Coronary Stenosis
BioNIR Ridaforolimus Eluting Coronary Stent System (BioNIR) In Coronary Stenosis Trial
Status: Enrolling
Updated: 3/25/2018
Piedmont Healthcare
2177
mi
from 98109
Atlanta, GA
Click here to add this to my saved trials
Study of BioNIR Drug Eluting Stent System in Coronary Stenosis
BioNIR Ridaforolimus Eluting Coronary Stent System (BioNIR) In Coronary Stenosis Trial
Status: Enrolling
Updated:  3/25/2018
ZNA Middelheim
4916
mi
from 98109
Antwerp,
Study of BioNIR Drug Eluting Stent System in Coronary Stenosis
BioNIR Ridaforolimus Eluting Coronary Stent System (BioNIR) In Coronary Stenosis Trial
Status: Enrolling
Updated: 3/25/2018
ZNA Middelheim
4916
mi
from 98109
Antwerp,
Click here to add this to my saved trials
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated:  3/26/2018
Victoria Heart and Vascular Center
1876
mi
from 98109
Victoria, TX
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated: 3/26/2018
Victoria Heart and Vascular Center
1876
mi
from 98109
Victoria, TX
Click here to add this to my saved trials
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated:  3/26/2018
Comprehensive Cardiovascular Medical Group
865
mi
from 98109
Bakersfield, CA
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated: 3/26/2018
Comprehensive Cardiovascular Medical Group
865
mi
from 98109
Bakersfield, CA
Click here to add this to my saved trials
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated:  3/26/2018
Texas Institute of Cardiology
1668
mi
from 98109
McKinney, TX
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated: 3/26/2018
Texas Institute of Cardiology
1668
mi
from 98109
McKinney, TX
Click here to add this to my saved trials
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated:  3/26/2018
Cardiology Consultants
2200
mi
from 98109
Pensacola, FL
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated: 3/26/2018
Cardiology Consultants
2200
mi
from 98109
Pensacola, FL
Click here to add this to my saved trials
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated:  3/26/2018
Tampa General Hospital
2527
mi
from 98109
Tampa, FL
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated: 3/26/2018
Tampa General Hospital
2527
mi
from 98109
Tampa, FL
Click here to add this to my saved trials
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated:  3/26/2018
MedStar Shah Medical Group
2348
mi
from 98109
Charlotte Hall, MD
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated: 3/26/2018
MedStar Shah Medical Group
2348
mi
from 98109
Charlotte Hall, MD
Click here to add this to my saved trials
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated:  3/26/2018
Advanced Cardiology Group
2112
mi
from 98109
Buffalo, NY
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated: 3/26/2018
Advanced Cardiology Group
2112
mi
from 98109
Buffalo, NY
Click here to add this to my saved trials
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated:  3/26/2018
University of Calgary
mi
from 98109
Calgary,
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated: 3/26/2018
University of Calgary
mi
from 98109
Calgary,
Click here to add this to my saved trials
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated:  3/26/2018
Yale-New Haven Hospital
2432
mi
from 98109
New Haven, CT
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated: 3/26/2018
Yale-New Haven Hospital
2432
mi
from 98109
New Haven, CT
Click here to add this to my saved trials
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated:  3/26/2018
Cardiology Physicians/Red Clay Research
2355
mi
from 98109
Newark, DE
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated: 3/26/2018
Cardiology Physicians/Red Clay Research
2355
mi
from 98109
Newark, DE
Click here to add this to my saved trials
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated:  3/26/2018
Bethesda Health
2696
mi
from 98109
Boynton Beach, FL
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated: 3/26/2018
Bethesda Health
2696
mi
from 98109
Boynton Beach, FL
Click here to add this to my saved trials
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated:  3/26/2018
South Miami Heart Specialists
2730
mi
from 98109
South Miami, FL
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated: 3/26/2018
South Miami Heart Specialists
2730
mi
from 98109
South Miami, FL
Click here to add this to my saved trials
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated:  3/26/2018
Northwestern University
1725
mi
from 98109
Evanston, IL
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated: 3/26/2018
Northwestern University
1725
mi
from 98109
Evanston, IL
Click here to add this to my saved trials
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated:  3/26/2018
WakeMed
2364
mi
from 98109
Raleigh, NC
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated: 3/26/2018
WakeMed
2364
mi
from 98109
Raleigh, NC
Click here to add this to my saved trials
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated:  3/26/2018
Houston Methodist Hospital
1892
mi
from 98109
Houston, TX
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated: 3/26/2018
Houston Methodist Hospital
1892
mi
from 98109
Houston, TX
Click here to add this to my saved trials
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated:  3/26/2018
VA Connecticut Healthcare System (VACHS)
2432
mi
from 98109
West Haven, CT
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated: 3/26/2018
VA Connecticut Healthcare System (VACHS)
2432
mi
from 98109
West Haven, CT
Click here to add this to my saved trials
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated:  3/26/2018
University of Florida Health - Jacksonville
2449
mi
from 98109
Jacksonville, FL
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated: 3/26/2018
University of Florida Health - Jacksonville
2449
mi
from 98109
Jacksonville, FL
Click here to add this to my saved trials
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated:  3/26/2018
University of South Florida
2523
mi
from 98109
Tampa, FL
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated: 3/26/2018
University of South Florida
2523
mi
from 98109
Tampa, FL
Click here to add this to my saved trials
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated:  3/26/2018
Augusta University
2300
mi
from 98109
Augusta, GA
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated: 3/26/2018
Augusta University
2300
mi
from 98109
Augusta, GA
Click here to add this to my saved trials
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated:  3/26/2018
MMP ME Health Cardiology
2481
mi
from 98109
Scarborough, ME
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated: 3/26/2018
MMP ME Health Cardiology
2481
mi
from 98109
Scarborough, ME
Click here to add this to my saved trials
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated:  3/26/2018
Boston Med Ctr
2485
mi
from 98109
Boston, MA
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated: 3/26/2018
Boston Med Ctr
2485
mi
from 98109
Boston, MA
Click here to add this to my saved trials
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated:  3/26/2018
Department of Cardiology, K-14 (Henry Ford Health System)
1930
mi
from 98109
Detroit, MI
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated: 3/26/2018
Department of Cardiology, K-14 (Henry Ford Health System)
1930
mi
from 98109
Detroit, MI
Click here to add this to my saved trials
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated:  3/26/2018
University at Buffalo
2112
mi
from 98109
Buffalo, NY
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated: 3/26/2018
University at Buffalo
2112
mi
from 98109
Buffalo, NY
Click here to add this to my saved trials
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated:  3/26/2018
Vascular Biology and Hypertension Program, University of Alabama at Birmingham
2080
mi
from 98109
Birmingham, AL
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated: 3/26/2018
Vascular Biology and Hypertension Program, University of Alabama at Birmingham
2080
mi
from 98109
Birmingham, AL
Click here to add this to my saved trials
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated:  3/26/2018
Sharp Grossmont Hospital
1063
mi
from 98109
La Mesa, CA
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated: 3/26/2018
Sharp Grossmont Hospital
1063
mi
from 98109
La Mesa, CA
Click here to add this to my saved trials
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated:  3/26/2018
Veterans Affairs North Texas Healthcare System
1685
mi
from 98109
Dallas, TX
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated: 3/26/2018
Veterans Affairs North Texas Healthcare System
1685
mi
from 98109
Dallas, TX
Click here to add this to my saved trials
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated:  3/26/2018
Regions Hospital and Regions Heart Center Clinic
1399
mi
from 98109
Saint Paul, MN
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated: 3/26/2018
Regions Hospital and Regions Heart Center Clinic
1399
mi
from 98109
Saint Paul, MN
Click here to add this to my saved trials
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated:  3/26/2018
Montefiore Medical Center
2402
mi
from 98109
Bronx, NY
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated: 3/26/2018
Montefiore Medical Center
2402
mi
from 98109
Bronx, NY
Click here to add this to my saved trials
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated:  3/26/2018
University of Miami Hospital
2730
mi
from 98109
Miami, FL
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated: 3/26/2018
University of Miami Hospital
2730
mi
from 98109
Miami, FL
Click here to add this to my saved trials
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated:  3/26/2018
Rush University Medical Center
1730
mi
from 98109
Chicago, IL
International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Status: Enrolling
Updated: 3/26/2018
Rush University Medical Center
1730
mi
from 98109
Chicago, IL
Click here to add this to my saved trials
Mitral Implantation of TRAnscatheter vaLves
The Safety and Feasibility of the SAPIEN XTTM Transcatheter Heart Valve With NovaFlex and Ascendra Delivery Systems and SAPIEN 3 With Commander Delivery System in Patients With Symptomatic Severe Calcific Mitral Valve Disease With Severe Mitral Annular Calcification and Patients With Failing Mitral Surgical Rings or Bioprostheses Who Are Not Candidates for Mitral Valve Surgery.
Status: Enrolling
Updated:  3/27/2018
Cedars-Sinai Medica Center
962
mi
from 98109
Los Angeles, CA
Mitral Implantation of TRAnscatheter vaLves
The Safety and Feasibility of the SAPIEN XTTM Transcatheter Heart Valve With NovaFlex and Ascendra Delivery Systems and SAPIEN 3 With Commander Delivery System in Patients With Symptomatic Severe Calcific Mitral Valve Disease With Severe Mitral Annular Calcification and Patients With Failing Mitral Surgical Rings or Bioprostheses Who Are Not Candidates for Mitral Valve Surgery.
Status: Enrolling
Updated: 3/27/2018
Cedars-Sinai Medica Center
962
mi
from 98109
Los Angeles, CA
Click here to add this to my saved trials
Mitral Implantation of TRAnscatheter vaLves
The Safety and Feasibility of the SAPIEN XTTM Transcatheter Heart Valve With NovaFlex and Ascendra Delivery Systems and SAPIEN 3 With Commander Delivery System in Patients With Symptomatic Severe Calcific Mitral Valve Disease With Severe Mitral Annular Calcification and Patients With Failing Mitral Surgical Rings or Bioprostheses Who Are Not Candidates for Mitral Valve Surgery.
Status: Enrolling
Updated:  3/27/2018
Evanston Hospital / North Shore University HealthSystem
1725
mi
from 98109
Evanston, IL
Mitral Implantation of TRAnscatheter vaLves
The Safety and Feasibility of the SAPIEN XTTM Transcatheter Heart Valve With NovaFlex and Ascendra Delivery Systems and SAPIEN 3 With Commander Delivery System in Patients With Symptomatic Severe Calcific Mitral Valve Disease With Severe Mitral Annular Calcification and Patients With Failing Mitral Surgical Rings or Bioprostheses Who Are Not Candidates for Mitral Valve Surgery.
Status: Enrolling
Updated: 3/27/2018
Evanston Hospital / North Shore University HealthSystem
1725
mi
from 98109
Evanston, IL
Click here to add this to my saved trials
Mitral Implantation of TRAnscatheter vaLves
The Safety and Feasibility of the SAPIEN XTTM Transcatheter Heart Valve With NovaFlex and Ascendra Delivery Systems and SAPIEN 3 With Commander Delivery System in Patients With Symptomatic Severe Calcific Mitral Valve Disease With Severe Mitral Annular Calcification and Patients With Failing Mitral Surgical Rings or Bioprostheses Who Are Not Candidates for Mitral Valve Surgery.
Status: Enrolling
Updated:  3/27/2018
Massachusetts General Hospital
2485
mi
from 98109
Boston, MA
Mitral Implantation of TRAnscatheter vaLves
The Safety and Feasibility of the SAPIEN XTTM Transcatheter Heart Valve With NovaFlex and Ascendra Delivery Systems and SAPIEN 3 With Commander Delivery System in Patients With Symptomatic Severe Calcific Mitral Valve Disease With Severe Mitral Annular Calcification and Patients With Failing Mitral Surgical Rings or Bioprostheses Who Are Not Candidates for Mitral Valve Surgery.
Status: Enrolling
Updated: 3/27/2018
Massachusetts General Hospital
2485
mi
from 98109
Boston, MA
Click here to add this to my saved trials
Mitral Implantation of TRAnscatheter vaLves
The Safety and Feasibility of the SAPIEN XTTM Transcatheter Heart Valve With NovaFlex and Ascendra Delivery Systems and SAPIEN 3 With Commander Delivery System in Patients With Symptomatic Severe Calcific Mitral Valve Disease With Severe Mitral Annular Calcification and Patients With Failing Mitral Surgical Rings or Bioprostheses Who Are Not Candidates for Mitral Valve Surgery.
Status: Enrolling
Updated:  3/27/2018
Henry Ford Hospital
1930
mi
from 98109
Detroit, MI
Mitral Implantation of TRAnscatheter vaLves
The Safety and Feasibility of the SAPIEN XTTM Transcatheter Heart Valve With NovaFlex and Ascendra Delivery Systems and SAPIEN 3 With Commander Delivery System in Patients With Symptomatic Severe Calcific Mitral Valve Disease With Severe Mitral Annular Calcification and Patients With Failing Mitral Surgical Rings or Bioprostheses Who Are Not Candidates for Mitral Valve Surgery.
Status: Enrolling
Updated: 3/27/2018
Henry Ford Hospital
1930
mi
from 98109
Detroit, MI
Click here to add this to my saved trials
Mitral Implantation of TRAnscatheter vaLves
The Safety and Feasibility of the SAPIEN XTTM Transcatheter Heart Valve With NovaFlex and Ascendra Delivery Systems and SAPIEN 3 With Commander Delivery System in Patients With Symptomatic Severe Calcific Mitral Valve Disease With Severe Mitral Annular Calcification and Patients With Failing Mitral Surgical Rings or Bioprostheses Who Are Not Candidates for Mitral Valve Surgery.
Status: Enrolling
Updated:  3/27/2018
The Mayo Clinic
1450
mi
from 98109
Rochester, MN
Mitral Implantation of TRAnscatheter vaLves
The Safety and Feasibility of the SAPIEN XTTM Transcatheter Heart Valve With NovaFlex and Ascendra Delivery Systems and SAPIEN 3 With Commander Delivery System in Patients With Symptomatic Severe Calcific Mitral Valve Disease With Severe Mitral Annular Calcification and Patients With Failing Mitral Surgical Rings or Bioprostheses Who Are Not Candidates for Mitral Valve Surgery.
Status: Enrolling
Updated: 3/27/2018
The Mayo Clinic
1450
mi
from 98109
Rochester, MN
Click here to add this to my saved trials